๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for AML/MDS

A Phase Ib Study of APG-115 Single Agent or in Combination With Azacitidine or Cytarabine in Patients With AML and MDS. NCT04275518Phase 114 sites๐Ÿ“ Beijing๐Ÿ“ Guangzhou๐Ÿ“ Guangzhou Ascentage Pharma Group Inc. ยท Tests: APG-115, Azacitidine, Cytarabine Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors NCT02508038Phase 11 site๐Ÿ“ Madison University of Wisconsin, Madison ยท Tests: TCRฮฑฮฒ+/CD19+ depleted Haploidentical HSCT, Zoledronate A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias NCT06994676Phase 111 sites๐Ÿ“ Duarte๐Ÿ“ Palo Alto๐Ÿ“ Tampa Crossbow Therapeutics, Inc. ยท Tests: CBX-250 Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant NCT06996119Phase 11 site๐Ÿ“ Duarte City of Hope Medical Center ยท Tests: Biospecimen Collection, Busulfan, Computed Tomography, Cyclophosphamide, Echocardiography Test Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen NCT06532084Phase 21 site๐Ÿ“ Saint Petersburg St. Petersburg State Pavlov Medical University ยท Tests: Sorafenib CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome NCT04493164Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Ivosidenib, Liposome-encapsulated Daunorubicin-Cytarabine Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation NCT06138587Phase 12 sites๐Ÿ“ Boston๐Ÿ“ Boston Dana-Farber Cancer Institute ยท Tests: Cytokine Induced Memory-like Natural Killer Cells, Interleukin-2 A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) NCT01351545n/a142 sites๐Ÿ“ Birmingham๐Ÿ“ Gilbert๐Ÿ“ Phoenix Center for International Blood and Marrow Transplant Researโ€ฆ ยท Tests: A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) A Telehealth Advance Care Planning Intervention NCT05875805NA1 site๐Ÿ“ Rochester University of Rochester ยท Tests: Telehealth Serious Illness Care Program, Education Control A Long Term Follow-up Study of TScan TCR-T Products NCT06976736n/a2 sites๐Ÿ“ Duarte๐Ÿ“ New York TScan Therapeutics, Inc. ยท Tests: Observational A Prospective, Multicenter, and Exploratory Study of CMGV in the Treatment of Recurrent Adult AML and MDS-EB-2/Elder AML NCT06329999NA1 site๐Ÿ“ Shanghai Ruijin Hospital ยท Tests: CMGV Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched Donor NCT07238712Phase 21 site๐Ÿ“ Saint Petersburg St. Petersburg State Pavlov Medical University ยท Tests: Ruxolitinib, Abatacept (Orencia) Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation NCT06793410Phase 25 sites๐Ÿ“ Lund๐Ÿ“ Stockholm๐Ÿ“ Uppsala Vastra Gotaland Region ยท Tests: Early start post-transplant vaccination with Gardasil 9ยฎ, Late post-transplant vaccination with Gardasil 9ยฎ A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies NCT06906380n/a3 sites๐Ÿ“ Charlotte๐Ÿ“ Winston-Salem๐Ÿ“ Houston ARCE Therapeutics, Inc. ยท Tests: Non interventional study Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML/HR-MDS and in Combination With Azacitidine in Previously Untreated HR-MDS NCT06533761Phase 112 sites๐Ÿ“ Duarte๐Ÿ“ Aurora๐Ÿ“ Tampa Stelexis BioSciences ยท Tests: Eganelisib, Eganelisib in combination with cytarabine, Eganelisib in combination with azacitidine, Azacitadine (AZA) A Study Using Subject-specific MRD to Adopt Treatment After HSCT for Subjects With MDS NCT05788679Phase 21 site๐Ÿ“ Stockholm Karolinska University Hospital ยท Tests: Azacitidine, Donor lymphocytes, Tapering of immune suppression Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome NCT04047641Phase 1, Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Cladribine, Cytarabine, Idarubicin, Quizartinib Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome NCT03661307Phase 1, Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Decitabine, Quizartinib, Venetoclax Venetoclax Basket Trial for High Risk Hematologic Malignancies NCT05292664Phase 15 sites๐Ÿ“ San Francisco๐Ÿ“ Aurora๐Ÿ“ Atlanta Andrew E. Place, MD ยท Tests: Venetoclax, Azacitidine, Cytarabine, Methotrexate, Hydrocortisone Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer NCT01137643n/a1 site๐Ÿ“ Chapel Hill UNC Lineberger Comprehensive Cancer Center ยท Tests: biologic sample preservation procedure, cytology specimen collection procedure CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant NCT06059391Phase 23 sites๐Ÿ“ Duarte๐Ÿ“ Atlanta๐Ÿ“ Boston City of Hope Medical Center ยท Tests: Allogeneic Hematopoietic Stem Cell Transplantation, Biospecimen Collection, Granulocyte Colony-Stimulating Factor, Hemaโ€ฆ Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression NCT07155226Phase 1, Phase 230 sites๐Ÿ“ Decatur๐Ÿ“ New York๐Ÿ“ Chapel Hill AstraZeneca ยท Tests: AZD3632, Posaconazole A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome NCT04243785Phase 13 sites๐Ÿ“ Duarte๐Ÿ“ New York๐Ÿ“ Houston Edgewood Oncology Inc. ยท Tests: BTX-A51, Azacitidine Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Impairment NCT04953910Phase 122 sites๐Ÿ“ Houston๐Ÿ“ Yerevan๐Ÿ“ Yerevan Taiho Oncology, Inc. ยท Tests: ASTX727 Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood NCT06904482Phase 21 site๐Ÿ“ Cleveland Case Comprehensive Cancer Center ยท Tests: Haplo-Identical / Cord Blood Transplant Fludarabine Plus Melphalan Versus Addition of Venetoclax to Fludarabine/Melphalan Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients Aged > 50 Years: a Multicenter, Randomized, Phase 3 Trial NCT07396480Phase 318 sites๐Ÿ“ Fuzhou๐Ÿ“ Guangzhou๐Ÿ“ Zhengzhou First Affiliated Hospital of Zhejiang University ยท Tests: Venetoclax in combination with fludarabine and melphalan, Fludarabine and Melphalan Proton-Based Total Marrow Irradiation for Allogeneic Transplantation in High-Risk AML/MDS NCT07532824Phase 1, Phase 22 sites๐Ÿ“ Prague๐Ÿ“ Prague Institute of Hematology and Blood Transfusion, Czech Republโ€ฆ ยท Tests: Proton Total Marrow Irradiation MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial) NCT05564390Phase 2360 sites๐Ÿ“ Birmingham๐Ÿ“ Phoenix๐Ÿ“ Tucson National Cancer Institute (NCI) ยท Tests: Allogeneic Hematopoietic Stem Cell Transplantation, Azacitidine, Azacitidine, Best Practice, Biopsy Procedure CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRฮฑฮฒ/CD19 Depleted HSCT NCT03810196NA1 site๐Ÿ“ Philadelphia Children's Hospital of Philadelphia ยท Tests: CliniMACS Cell Processing System for TCRฮฑฮฒ + T Cell and CD45RA Depleted Peripheral Stem Cell Addback Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant NCT03850418Phase 21 site๐Ÿ“ Detroit Henry Ford Health System ยท Tests: azacitidine
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy